The main findings of this study are that heterogenous gastrin receptor (CCK2R) expression can be detected both in cultured and clinical melanoma samples, and that elevated serum gastrin concentrations exhibit an association with melanoma thickness; a well-known risk factor of melanoma progression. The gene discussed is GAST; the disease is melanoma.